WHO ICTRP trial
Evaluation of the effect of vaginal progesterone administration on…
IRCT20151228025732N72 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20151228025732N72 |
|---|---|
| Public title | Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsia |
| Scientific title | Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsia |
| Primary sponsor | Semnan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | High risk pregnancy. Supervision of high risk pregnancy |
| Interventions | Intervention 1: Intervention group: In this group; Treatment with oral aspirin tablets (Cardiosprin 80 grams, manufactured by Samisaz, Iran) on a daily basis from the 12th week of pregnancy to the 36th week; Together with vaginal… |
| Registration date | Sep 5, 2022 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: